Our factory specializes in the R&D, production, and sales of Dimethyl Sulfoxide (DMSO) as a pharmaceutical excipient and holds the properprotuctionficense for pharmacuical excirients We stictly foiow GMPguidetines in our manutfaetuing and operations, and rely on a stringent quality control system and advanced production processes to ensure that our products comply with multiple pharmacopoeia standards, including the Chinese Pharmacopocia (ChP), United States Pharmacopocia (USP), and European Pharmacopocia (EP),thereby meeting the diverse demands forhigh-puriy DMSO across the pharmaceutical,biotechnology,cosmetics,and scientifie research sectors.

Beyond our core product, DMSO,our portfolio encompasses other pharmaccutical exeipicnts, R&Din bio-based materials,medical protective products, and chemical trading. This forms a comprehensive business structure centered on pharmaceutical excipients with coordinated development across related sectors.

In terms of technological research and development, Jamo is deeply engaged in the innovative integration of medicine and engineering. To this end, we have established our proprietary innovation platform. The platform brings together top-tier scientific talents with core team members from renowned domestic and international research institutions and universities, including Tsinghua University Qiyuan Laboratory, Yale University School of Engineering & Applied Science (SEAS), Northwestern University, and Fudan University School of Medicine. Furthermore, the platform collaborates closely with professional medical institutions such as the Medical College of China Three Gorges University, Shanghai Tenth People's Hospital, and Renhe Hospital focusing on clinical medical research, development, and manufacturing of AI-powered intelligent medical devices.

Currently, our independently developed wireless smart spinal endoscope has entered the testing phase. Moving forward, we will continue to launch multiple high-end smart medical devices that address critical clinical needs, leveraging technological innovation to empower the development of the broader healthcare industry and safeguard public’s health.